MPI Research provides preclinical services to agricultural, environmental, biopharmaceutical, medical device, animal health, and chemical industries. MPI Research has conducted thousands of studies in both small and large molecules in a wide and diverse range of compound classes, through all routes of administration (excluding inhalation) and offers studies with numerous species and models. Our recent achievements warrant a closer look to see how we’ve expanded to integrate the full spectrum of services for new drug and device candidates.
MPI Research also has a focus on efficacy testing and has a strong presence within the cellular and molecular biology fields, biomarkers, and gene therapy. With ample physical and technical capacity, we can accommodate multiple requirements simultaneously, adjust schedules readily, and produce results quickly.
MPI Research Study Directors and Scientists are uniquely accessible on a real-time basis and are diligent at keeping Sponsors informed as developments unfold, from collaboration on the initial program design through final report.
Taking you further. Explore more at www.mpiresearch.com.
MPI Research also has a focus on efficacy testing and has a strong presence within the cellular and molecular biology fields, biomarkers, and gene therapy. With ample physical and technical capacity, we can accommodate multiple requirements simultaneously, adjust schedules readily, and produce results quickly.
MPI Research Study Directors and Scientists are uniquely accessible on a real-time basis and are diligent at keeping Sponsors informed as developments unfold, from collaboration on the initial program design through final report.
Taking you further. Explore more at www.mpiresearch.com.
Location: United States, Michigan, Mattawan
Employees: 1001-5000
Founded date: 1995
Investors 1
| Date | Name | Website |
| - | Avista Cap... | avistacap.... |
Mentions in press and media 3
| Date | Title | Description |
| 15.02.2018 | Term Sheet — Thursday, February 15 | SO LONG, SAN FRANCISCO Good morning, Term Sheet readers. Paid Content Securing the enterprise without boundaries From ExtraHop Mr. Thiel has long stood out in Silicon Valley for his vocal libertarianism, but he drew heavy criticism from man... |
| 06.06.2012 | Kineta, Playing for Bunt Singles, Builds a Biotech Company Without VC Bucks | Share Share on Facebook Share on Twitter LinkedIn Email Reprints One of the best-financed biotech startups in Seattle of the last five years hasn’t raised a dime of traditional venture capital. If Kineta can show it delivers returns without... |
| - | Charles River Laboratories Completes the Acquisition of MPI Research | WILMINGTON, Mass.–(BUSINESS WIRE)–Apr. 3, 2018– Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously announced acquisition of MPI Research for approximately $800 million in cash, su... |